Using single-cell analysis of B cell acute lymphoblastic leukemia (B-ALL) patient samples, Witkowski et al. show that the frequency of non-classical monocytes predicts patient survival. Depletion of these monocytes improves treatment responsiveness in animal models of high-risk B-ALL.
from Cancer Cell https://ift.tt/2ZKkVO7
from Cancer Cell https://ift.tt/2ZKkVO7